In addition, down‐regulation of METTL14 in renal cell carcinoma was related to poor prognosis, and that METTL14 regulated PTEN expression via m6A modification, which indicated that METTL14 could possibly serve as a prognostic biomarker.39 This evidence concerns the gene METTL14 and hereditary clear cell renal cell carcinoma.